- Home
- Publications
- Publication Search
- Publication Details
Title
B7-H3 in tumors: friend or foe for tumor immunity?
Authors
Keywords
B7-H3, Expression, Co-stimulatory, Co-inhibitory, Tumor immunity, Cancer immunotherapy
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 81, Issue 2, Pages 245-253
Publisher
Springer Nature
Online
2018-01-03
DOI
10.1007/s00280-017-3508-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B7-H3 promotes gastric cancer cell migration and invasion
- (2017) Yecheng Li et al. Oncotarget
- B7-H3 Promotes the Migration and Invasion of Human Bladder Cancer Cells via the PI3K/Akt/STAT3 Signaling Pathway
- (2017) Yuchao Li et al. Journal of Cancer
- Upregulation of soluble B7-H3 in NSCLC-derived malignant pleural effusion: A potential diagnostic biomarker correlated with NSCLC staging
- (2016) Liwen Chen et al. CLINICA CHIMICA ACTA
- Preparation and application of a novel monoclonal antibody specific for human B7-H3
- (2016) JIAN SHI et al. Molecular Medicine Reports
- Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
- (2016) B Benzon et al. PROSTATE CANCER AND PROSTATIC DISEASES
- B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy
- (2016) Juan Ma et al. Oncotarget
- Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway
- (2016) Chao Xie et al. Scientific Reports
- Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging
- (2015) S. V. Bachawal et al. CANCER RESEARCH
- ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer
- (2015) Pei Zhang et al. FEBS LETTERS
- B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell Subsets
- (2015) Liqun Luo et al. PLoS One
- Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3
- (2015) Ting Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells
- (2015) Wei Zhang et al. OncoTargets and Therapy
- Expression levels of B7-H3 and TLT-2 in human oral squamous cell carcinoma
- (2015) SHAN-SHAN ZHANG et al. Oncology Letters
- Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer
- (2015) K. Kreymborg et al. Cancer Immunology Research
- Expression of B7-H3, a Potential Factor of Tumor Immune Evasion in Combination with the Number of Regulatory T Cells, Affects Against Recurrence-Free Survival in Breast Cancer Patients
- (2014) N. Maeda et al. ANNALS OF SURGICAL ONCOLOGY
- B7-H3 expression in breast cancer and upregulation of VEGF through gene silence
- (2014) Jing Sun et al. OncoTargets and Therapy
- Targeting T Cell Immunometabolism for Cancer Immunotherapy; Understanding the Impact of the Tumor Microenvironment
- (2014) Mary B. Mockler et al. Frontiers in Oncology
- The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy
- (2014) Joanne Leung et al. Immune Network
- Monoclonal antibody-based immunotherapy of ovarian cancer: Targeting ovarian cancer cells with the B7-H3-specific mAb 376.96
- (2013) Janelle M. Fauci et al. GYNECOLOGIC ONCOLOGY
- B7-H3-mediated tumor immunology: Friend or foe?
- (2013) Ling Wang et al. INTERNATIONAL JOURNAL OF CANCER
- B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma
- (2013) Jinhua Wang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- B7-H3 is Overexpressed in Patients Suffering Osteosarcoma and Associated with Tumor Aggressiveness and Metastasis
- (2013) Ling Wang et al. PLoS One
- HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function
- (2013) R. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
- (2013) Vladimir Vigdorovich et al. STRUCTURE
- The role of B7 family molecules in hematologic malignancy
- (2012) P. Greaves et al. BLOOD
- B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence
- (2012) Tai-Wei Sun et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
- (2012) D. Loo et al. CLINICAL CANCER RESEARCH
- Tumor B7-H1 and B7-H3 Expression in Squamous Cell Carcinoma of the Lung
- (2012) Jennifer M. Boland et al. Clinical Lung Cancer
- A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer
- (2012) Janelle M. Fauci et al. GYNECOLOGIC ONCOLOGY
- B7-H3 overexpression in pancreatic cancer promotes tumor progression
- (2012) XIN ZHAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- B7-H3 expression in ductal and lobular breast cancer and its association with IL-10
- (2012) CHUANYONG LIU et al. Molecular Medicine Reports
- B7-H3 expression in gastric cancer: A novel molecular blood marker for detecting circulating tumor cells
- (2011) Takaaki Arigami et al. CANCER SCIENCE
- Costimulatory Protein 4IgB7H3 Drives the Malignant Phenotype of Glioblastoma by Mediating Immune Escape and Invasiveness
- (2011) D. Lemke et al. CLINICAL CANCER RESEARCH
- Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis
- (2011) Katayama INTERNATIONAL JOURNAL OF ONCOLOGY
- B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression
- (2011) Hexing Yuan et al. JOURNAL OF UROLOGY
- Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma
- (2010) Jing Sun et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- B7-H3 and Its Role in Antitumor Immunity
- (2010) Martin Loos et al. Clinical & Developmental Immunology
- Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: Immunotherapeutic implications
- (2010) Luana Calabrò et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
- (2010) Xingxing Zang et al. MODERN PATHOLOGY
- Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer
- (2009) Martin Loos et al. BMC CANCER
- Clinical importance of B7-H3 expression in human pancreatic cancer
- (2009) I Yamato et al. BRITISH JOURNAL OF CANCER
- MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors
- (2009) H. Xu et al. CANCER RESEARCH
- B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction
- (2009) Judith Leitner et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Fine tuning the immune response through B7-H3 and B7-H4
- (2009) Kyung H. Yi et al. IMMUNOLOGICAL REVIEWS
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum
- (2008) Guangbo Zhang et al. IMMUNOLOGY
- Transgenic B7-H3 therapy induces tumor-specific immune response in human oral squamous cell cancer: an in vitro study
- (2008) Hong Y. Yang et al. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
- The contrasting role of B7-H3
- (2008) K. A. Hofmeyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses
- (2008) M. Hashiguchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now